BioSpace News Archive

BioMidwest

DaVita Inc. Schedules 4th Quarter 2022 Investor Conference Call

DaVita Inc., announced that it will hold its quarterly conference call to discuss fourth quarter and full year results on Wednesday, February 22, 2023, at 5:00 p.m. Eastern Time.

February 1, 2023

·

1 min read

Business

ProSomnus® Provides Business Update and Preliminary 2022 Revenue Guidance

ProSomnus, Inc., a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea, announced certain unaudited results for the quarter and full year ended December 31, 2022.

February 1, 2023

·

7 min read

FDA

FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis

Today, the U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood cells) caused by chronic kidney disease for adults who have been receiving dialysis for at least four months.

February 1, 2023

·

3 min read

Business

Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, March 1, 2023

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2022 results on Wednesday, March 1, 2023.

February 1, 2023

·

1 min read

Business

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results on February 8, 2023

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2022 on Wednesday, February 8, 2023, after the market closes.

February 1, 2023

·

1 min read

Lone Star Bio

Castle Biosciences Earns a Top Workplaces USA Award for the Second Consecutive Year

Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced that it has received a 2023 Top Workplaces USA award from Energage.

February 1, 2023

·

3 min read

Business

St. Luke’s Health and Baylor College of Medicine Reach Equitable Agreement with Cigna

St. Luke’s Health and its academic affiliate Baylor College of Medicine are back in-network with Cigna, adding the insurer to a large group of in-network carriers.

February 1, 2023

·

2 min read

Business

Elizabeth Keiley Selected as Executive Vice President and General Counsel of vTv Therapeutics

vTv Therapeutics Inc., a clinical stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes, announced the appointment of Elizabeth Keiley as Executive Vice President and General Counsel, effective immediately.

February 1, 2023

·

4 min read

Biotech Bay

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock - February 02, 2023

Vera Therapeutics, Inc. announced the pricing of its previously announced underwritten public offering of 14,285,715 shares of its Class A common stock at a price to the public of $7.00 per share.

February 1, 2023

·

4 min read

Business

Vaxxinity Announces Board Appointments and Establishes New Headquarters in Florida

Vaxxinity, Inc., a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, announced new appointments to the Board of Directors and the relocation of its corporate headquarters to Cape Canaveral, Fla.

February 1, 2023

·

5 min read